Sort
82,697 grants matching “vaccine development”
Administrative Core - Galveston National Laboratory BSL4 Operations
$1,964,926James W. Leduc · University Of Texas Med Br Galveston · UC7 · FY2019 · AI
Dynamics and Evolution of Immune Responses to Influenza Viruses
$1,964,352Rustom Noshir Antia · Emory University · U19 · FY2018 · AI
HIV VACCINES TRIAL UNITS
$1,964,254Fred Hutchinson Cancer Research Center · U01 · FY2002 · AI
Consultation and Collaboration
$1,963,669Barry Graubard · Division Of Cancer Epidemiology And Genetics · ZIA · FY2011 · CA
Center of Excellence for Influenza Research and Surveillance
$1,963,297Robert Webster · St. Jude Children'S Research Hospital · N01 · FY2009 · AI
Role of Viral Reservoirs in the Pathogenesis of HIV Disease
$1,963,172Tae-Wook Chun · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
(HVTN) HIV VACCINE TRIAL UNITS
$1,962,396Johns Hopkins University · U01 · FY2001 · AI
Paramyxoviruses as Vaccine Vectors Against Highly Pathogenic Viruses
$1,962,239Peter Leon Collins · Niaid Extramural Activities · Z01 · FY2007 · AI
Enhancing T Cell Therapy of Cancer
$1,961,712Helen E Heslop · Baylor College Of Medicine · P01 · FY2009 · CA
Multidimensional development of high-affinity anti-glycan antibodies to fight deadly bacterial infections
$1,961,391Luc Teyton · Scripps Research Institute, The · P01 · FY2025 · AI
Producing Polyclonal Human Antibodies to Anthrax
$1,961,370Hematech, Llc · R44 · FY2004 · AI
Structure-Function Studies of the HIV-1 Envelope Glycoproteins
$1,961,140Paolo Lusso · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Center for Integrative Research on Childhood Adversity
$1,960,968Jennifer Hays-Grudo · Osu Center For Health Sciences · P20 · FY2022 · GM
An Orbitrap Astral Mass Spectrometer for Elevating Proteomics Sensitivity at Rutgers Biomedical and Health Sciences Newark Campus
$1,960,930Hong Li · Rutgers Biomedical And Health Sciences · S10 · FY2025 · OD
HIV-1 Vaccine Based on Chimp Serotypes of Adenovirus
$1,960,770Wistar Institute · P01 · FY2005 · AI
Characterization of the cellular and molecular bases of inborn errors of immunity
$1,960,459Luigi Notarangelo · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Aging and Immunity to Infections
$1,960,315Trudeau Institute, Inc. · P01 · FY2004 · AG
New Approaches to the Biology and Treatment of Myelodysplastic Syndromes (MDS)
$1,960,280University Of Texas Md Anderson Can Ctr · P01 · FY2005 · CA
Development of a recombinant protein vaccine for Chlamydia trachomatis
$1,959,365Toni Darville · Univ Of North Carolina Chapel Hill · U01 · FY2024 · AI
Yellow Fever, rDNA (EP+IL-12) and rAd35 as Vectors for AIDS Vaccine Development
$1,956,887David I Watkins · University Of Miami School Of Medicine · P01 · FY2015 · AI
TASK ORDER B-15: Model Development and Medical Countermeasure Evaluation
$1,956,086Niurka De Leon · Boston University Medical Campus · N01 · FY2022 · AI
Simian Vaccine Evaluation Unit: Operation of a Nonhuman Primate Breeding Colony
$1,955,151Francois Villinger · University Of Louisiana At Lafayette · N01 · FY2024 · AI
Recombinant Subunit Vaccine/Prevention of West Nile Vir*
$1,954,843Hawaii Biotech, Inc. · R44 · FY2004 · NS
PDT - Mechanisms and Strategies for Optimization
$1,954,061Barbara W. Henderson · Roswell Park Cancer Institute Corp · P01 · FY2013 · CA
Noroviruses and Epidemic Gastroenteritis
$1,953,910Kim Y. Green · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI